Mensinger Mike 4
4 · Beta Bionics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Mensinger Mike
Chief Product Officer
Transactions
- Sale
Common Stock
2026-01-02$29.56/sh−7,200$212,832→ 83,552 total - Sale
Common Stock
2026-01-02$30.20/sh−600$18,118→ 82,952 total
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.
- [F2]The weighted average sale price for the transaction reported was $29.56 and the range of prices were between $29.05 and $30.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $30.1969 and the range of prices were between $30.10 and $30.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.